Icu Medical Inc/de
A maker of infusion therapy and IV safety products headquartered in San Clemente, California, ICU Medical produces the Plum family of infusion pumps, needle-free connectors like the MicroClave, and IV sets used by hospitals and clinics around the world. Physician Dr. George "Doc" Lopez founded the company in 1984 after inventing a device to better secure intravenous lines; the name comes from the Intensive Care Unit. Its best-known invention is the Clave needleless connector, which lets staff connect syringes and IV lines without ever touching a needle.
Sold 830.0K
Sold 830.0K
Granted 94.9K · Bought 25.8K · Sold 50.9K
Granted 610.2K · Bought 21.9K · Sold 193.4K
Granted 49.8K · Sold 14.0K
Sold 2.2K
Granted 64.3K · Sold 12.0K
Granted 2.7K
Granted 8.6K · Sold 5.0K
Granted 4.8K
Granted 4.8K
Granted 4.8K
Granted 4.5K
Granted 10.2K · Bought 1.2K · Sold 5.3K
Granted 209.6K · Sold 96.0K
Granted 18.5K · Sold 4.0K
Granted 142.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Smiths Group PLCFormer 10% Owner · 1 transaction | — | 1.67Mas of Feb 2024 | — | — | 830.0K |
| Smiths Group International Holdings LtdFormer 10% Owner · 1 transaction | — | 1.67Mas of Feb 2024 | — | — | 830.0K |
| Lopez George ADirector · 12 transactions | +6% | 1.20Mas of Mar 2024 | 94.9K | 25.8K | 50.9K |
| Jain VivekChairman and CEO, Director · 104 transactions | +167% | 371.2K | 610.2K | 21.9K | 193.4K |
| Woolson DanielPresident · 41 transactions | +1456.7% | 22.5K | 49.8K | — | 14.0K |
| Swinney Robert SDirector · 1 transaction | -9% | 21.9Kas of Sep 2021 | — | — | 2.2K |
| Sanzone Virginia RuthVP, General Counsel · 48 transactions | +709.1% | 19.5K | 64.3K | — | 12.0K |
| McGrody Kevin JChief Accounting Officer · 6 transactions | -33.3% | 1.7Kas of Mar 2022 | 2.7K | — | — |
| Finney Elisha WDirector · 14 transactions | +240.6% | 1.5K | 8.6K | — | 5.0K |
| Abbey DonaldDirector · 6 transactions | — | 1.5K | 4.8K | — | — |
| Hernandez LaurieDirector · 5 transactions | +1375% | 1.5K | 4.8K | — | — |
| Hoffmeister David FDirector · 5 transactions | — | 1.5K | 4.8K | — | — |
| Kennedy Kolleen TDirector · 5 transactions | — | 1.5K | 4.5K | — | — |
| Greenberg David C.Director · 13 transactions | -46.4% | 500 | 10.2K | 1.2K | 5.3K |
| Voigtlander Christian B.Chief Operating Officer · 70 transactions | -100% | 0 | 209.6K | — | 96.0K |
| Sousa BenChief Information Officer · 24 transactions | — | 0 | 18.5K | — | 4.0K |
| Bonnell Brian MichaelChief Financial Officer · 34 transactions | -100% | 0 | 142.2K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -1.99M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.